Literature DB >> 15121863

Dwarfism and impaired gut development in insulin-like growth factor II mRNA-binding protein 1-deficient mice.

Thomas V O Hansen1, Niels A Hammer, Jacob Nielsen, Mette Madsen, Charlotte Dalbaeck, Ulla M Wewer, Jan Christiansen, Finn C Nielsen.   

Abstract

Insulin-like growth factor II mRNA-binding protein 1 (IMP1) belongs to a family of RNA-binding proteins implicated in mRNA localization, turnover, and translational control. Mouse IMP1 is expressed during early development, and an increase in expression occurs around embryonic day 12.5 (E12.5). To characterize the physiological role of IMP1, we generated IMP1-deficient mice carrying a gene trap insertion in the Imp1 gene. Imp1(-/-) mice were on average 40% smaller than wild-type and heterozygous sex-matched littermates. Growth retardation was apparent from E17.5 and remained permanent into adult life. Moreover, Imp1(-/-) mice exhibited high perinatal mortality, and only 50% were alive 3 days after birth. In contrast to most other organs, intestinal epithelial cells continue to express IMP1 postnatally, and Imp1(-/-) mice exhibited impaired development of the intestine, with small and misshapen villi and twisted colon crypts. Analysis of target mRNAs and global expression profiling at E12.5 indicated that Igf2 translation was downregulated, whereas the postnatal intestine showed reduced expression of transcripts encoding extracellular matrix components, such as galectin- 1, lumican, tenascin-C, procollagen transcripts, and the Hsp47 procollagen chaperone. Taken together, the results demonstrate that IMP1 is essential for normal growth and development. Moreover, IMP1 may facilitate intestinal morphogenesis via regulation of extracellular matrix formation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15121863      PMCID: PMC400488          DOI: 10.1128/MCB.24.10.4448-4464.2004

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  61 in total

1.  Overexpression of an mRNA-binding protein in human colorectal cancer.

Authors:  J Ross; I Lemm; B Berberet
Journal:  Oncogene       Date:  2001-10-04       Impact factor: 9.867

2.  TFF2/SP-deficient mice show decreased gastric proliferation, increased acid secretion, and increased susceptibility to NSAID injury.

Authors:  James J Farrell; Douglas Taupin; Theodore J Koh; Duan Chen; Chun-Mei Zhao; Daniel K Podolsky; Timothy C Wang
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

3.  A pancreatic cancer-specific expression profile.

Authors:  T M Gress; F Müller-Pillasch; M Geng; F Zimmerhackl; G Zehetner; H Friess; M Büchler; G Adler; H Lehrach
Journal:  Oncogene       Date:  1996-10-17       Impact factor: 9.867

Review 4.  A family of IGF-II mRNA binding proteins (IMP) involved in RNA trafficking.

Authors:  F C Nielsen; J Nielsen; J Christiansen
Journal:  Scand J Clin Lab Invest Suppl       Date:  2001

Review 5.  Cyclase-associated proteins: CAPacity for linking signal transduction and actin polymerization.

Authors:  Andrew V Hubberstey; Emilio P Mottillo
Journal:  FASEB J       Date:  2002-04       Impact factor: 5.191

6.  C-MYC and IGF-II mRNA-binding protein (CRD-BP/IMP-1) in benign and malignant mesenchymal tumors.

Authors:  P Ioannidis; T Trangas; E Dimitriadis; M Samiotaki; I Kyriazoglou; C M Tsiapalis; C Kittas; N Agnantis; F C Nielsen; J Nielsen; J Christiansen; N Pandis
Journal:  Int J Cancer       Date:  2001-11       Impact factor: 7.396

7.  c-Myc regulates mammalian body size by controlling cell number but not cell size.

Authors:  A Trumpp; Y Refaeli; T Oskarsson; S Gasser; M Murphy; G R Martin; J M Bishop
Journal:  Nature       Date:  2001-12-13       Impact factor: 49.962

8.  Expression of mouse igf2 mRNA-binding protein 3 and its implications for the developing central nervous system.

Authors:  H Mori; S Sakakibara ; T Imai; Y Nakamura; T Iijima; A Suzuki; Y Yuasa; M Takeda; H Okano
Journal:  J Neurosci Res       Date:  2001-04-15       Impact factor: 4.164

9.  Defects in development of the kidney, heart and eye vasculature in mice homozygous for a hypomorphic Notch2 mutation.

Authors:  B McCright; X Gao; L Shen; J Lozier; Y Lan; M Maguire; D Herzlinger; G Weinmaster; R Jiang; T Gridley
Journal:  Development       Date:  2001-02       Impact factor: 6.868

10.  Embryonic lethality of molecular chaperone hsp47 knockout mice is associated with defects in collagen biosynthesis.

Authors:  N Nagai; M Hosokawa; S Itohara; E Adachi; T Matsushita; N Hosokawa; K Nagata
Journal:  J Cell Biol       Date:  2000-09-18       Impact factor: 10.539

View more
  89 in total

1.  Shared genetic architecture in the relationship between adult stature and subclinical coronary artery atherosclerosis.

Authors:  Andrea E Cassidy-Bushrow; Lawrence F Bielak; Patrick F Sheedy; Stephen T Turner; Julia S Chu; Patricia A Peyser
Journal:  Atherosclerosis       Date:  2011-08-30       Impact factor: 5.162

2.  When zip codes are in short supply.

Authors:  Rotem Ben-Tov Perry; Mike Fainzilber
Journal:  EMBO J       Date:  2011-11-16       Impact factor: 11.598

3.  Limited availability of ZBP1 restricts axonal mRNA localization and nerve regeneration capacity.

Authors:  Christopher J Donnelly; Dianna E Willis; Mei Xu; Chhavy Tep; Chunsu Jiang; Soonmoon Yoo; N Carolyn Schanen; Catherine B Kirn-Safran; Jan van Minnen; Arthur English; Sung Ok Yoon; Gary J Bassell; Jeffery L Twiss
Journal:  EMBO J       Date:  2011-09-30       Impact factor: 11.598

4.  Developmental and regional expression and localization of mRNAs encoding proteins involved in RNA translocation.

Authors:  Shabana Islam; Robert K Montgomery; John J Fialkovich; Richard J Grand
Journal:  J Histochem Cytochem       Date:  2005-07-11       Impact factor: 2.479

5.  RNA-binding IMPs promote cell adhesion and invadopodia formation.

Authors:  Jonas Vikesaa; Thomas V O Hansen; Lars Jønson; Rehannah Borup; Ulla M Wewer; Jan Christiansen; Finn C Nielsen
Journal:  EMBO J       Date:  2006-03-16       Impact factor: 11.598

6.  Lin-28 binds IGF-2 mRNA and participates in skeletal myogenesis by increasing translation efficiency.

Authors:  Anna Polesskaya; Sylvain Cuvellier; Irina Naguibneva; Arnaud Duquet; Eric G Moss; Annick Harel-Bellan
Journal:  Genes Dev       Date:  2007-05-01       Impact factor: 11.361

7.  Involvement of the mRNA binding protein CRD-BP in the regulation of metastatic melanoma cell proliferation and invasion by hypoxia.

Authors:  Evisabel A Craig; Jonathan D Weber; Vladimir S Spiegelman
Journal:  J Cell Sci       Date:  2012-10-04       Impact factor: 5.285

8.  mTOR complex 2 phosphorylates IMP1 cotranslationally to promote IGF2 production and the proliferation of mouse embryonic fibroblasts.

Authors:  Ning Dai; Jan Christiansen; Finn C Nielsen; Joseph Avruch
Journal:  Genes Dev       Date:  2013-02-01       Impact factor: 11.361

9.  The petit rat (pet/pet), a new semilethal mutant dwarf rat with thymic and testicular anomalies.

Authors:  Junko Chiba; Katsushi Suzuki; Hiroetsu Suzuki
Journal:  Comp Med       Date:  2008-12       Impact factor: 0.982

10.  Oncogenic NRAS, required for pathogenesis of embryonic rhabdomyosarcoma, relies upon the HMGA2-IGF2BP2 pathway.

Authors:  Zhizhong Li; Yunyu Zhang; Krishnan Ramanujan; Yan Ma; David G Kirsch; David J Glass
Journal:  Cancer Res       Date:  2013-03-27       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.